Myriad Genetics Inc (MYGN)
Return on assets (ROA)
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Net income | US$ in thousands | -127,300 | -263,300 | -112,000 | -27,200 | -223,700 |
Total assets | US$ in thousands | 1,027,600 | 1,146,500 | 1,198,700 | 1,320,700 | 1,418,800 |
ROA | -12.39% | -22.97% | -9.34% | -2.06% | -15.77% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $-127,300K ÷ $1,027,600K
= -12.39%
Myriad Genetics Inc's return on assets (ROA) has seen fluctuations over the years. In December 2020, the ROA was -15.77%, indicating that the company generated a net loss relative to its total assets during that period. There was a slight improvement in December 2021, with the ROA at -2.06%, suggesting a reduced net loss compared to the previous year.
However, the company's ROA deteriorated in December 2022 to -9.34%, signifying a decreased ability to generate profit from its assets. This negative trend continued in December 2023, with the ROA dropping further to -22.97%, indicating a significant decline in the company's profitability relative to its asset base.
In December 2024, there was a partial recovery as the ROA improved to -12.39%. While this is still negative, it shows a relative improvement compared to the previous year. Overall, Myriad Genetics Inc's ROA performance reflects a volatile financial position with periods of losses and challenges in effectively utilizing its assets to generate profits.
Peer comparison
Dec 31, 2024